The University of Cincinnati joins a Phase 1 clinical trial testing CAR-T cell therapy for MS, exploring this cancer ...

Replacing defective microglia can halt ALSP—a fatal neurodegenerative disease—in mice and humans, offering hope for broader brain therapies.

Scientists have discovered how a key protein helps maintain strong connections between brain cells that are crucial for ...

For decades, the story of Alzheimer's research has been dominated by a battle between A-beta and tau amyloids, both of which ...

During a live event, Jeffrey V. Matous, MD, discussed bispecific antibody treatment efficacy and safety in advanced multiple ...